HR7953
Senate
119th Congress
To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
Referred to the House Committee on Energy and Commerce.
Recent Activity
Referred to the House Committee on Energy and Commerce.
3/17/2026IntroReferral
Introduced in House
3/17/2026IntroReferral
Introduced in House
3/17/2026IntroReferral
Viewing 3 of 3 actions
Details
- Introduced
- 3/17/2026
![Rep. Sessions, Pete [R-TX-17]](https://unitedstates.github.io/images/congress/original/S000250.jpg)